Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 86404-63-9, is researched, SMILESS is FC1=CC=C(C(CN2N=CN=C2)=O)C(F)=C1, Molecular C10H7F2N3OJournal, Article, ACS Omega called Design, Synthesis, and In Vitro and In Vivo Evaluation of Novel Fluconazole-Based Compounds with Promising Antifungal Activities, Author is Shafiei, Mohammad; Toreyhi, Hossein; Firoozpour, Loghman; Akbarzadeh, Tahmineh; Amini, Mohsen; Hosseinzadeh, Elaheh; Hashemzadeh, Mehrnoosh; Peyton, Lee; Lotfali, Ensieh; Foroumadi, Alireza, the main research direction is fluconazole derivative antifungal broad spectrum azole antibiofilm.Product Details of 86404-63-9.
Demand has arisen for developing new azole antifungal agents with the growth of the resistant rate of infective fungal species to current azole antifungals in recent years. Accordingly, the present study reports the synthesis of novel fluconazole (FLC) analogs bearing urea functionality that led to discovering new azole agents with promising antifungal activities. In particular, compounds 8b (I) and 8c (II) displayed broad-spectrum activity and superior in vitro antifungal capabilities compared to the standard drug FLC against sensitive and resistant Candida albicans (C. albicans). The highly active compounds 8b and 8c had potent antibiofilm properties against FLC-resistant C. albicans species. Addnl., these compounds exhibited very low toxicity for three mammalian cell lines and human red blood cells. Time-kill studies revealed that our synthesized compounds displayed a fungicidal mechanism toward fungal growth. Furthermore, a d. functional theory (DFT) calculation, addnl. docking, and independent gradient model (IGM) studies were performed to analyze their structure-activity relationship (SAR) and to assess the mol. interactions in the related target protein. Finally, in vivo results represented a significant reduction in the tissue fungal burden and improvements in the survival rate in a mice model of systemic candidiasis along with in vitro and in silico studies, demonstrating the therapeutic efficiency of compounds 8b and 8c as novel leads for candidiasis drug discovery.
Although many compounds look similar to this compound(86404-63-9)Product Details of 86404-63-9, numerous studies have shown that this compound(SMILES:FC1=CC=C(C(CN2N=CN=C2)=O)C(F)=C1), has unique advantages. If you want to know more about similar compounds, you can read my other articles.
Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics